SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001126234-24-000006
Filing Date
2024-01-10
Accepted
2024-01-10 19:03:15
Documents
3
Period of Report
2024-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1704931382.html 3  
1 FORM 3 wk-form3_1704931382.xml 3 6815
2 EX-24 lumos-formidxpowerofatto.htm EX-24 2457
3 lumos-formidxpowerofatto001.jpg GRAPHIC 147886
  Complete submission text file 0001126234-24-000006.txt   214614
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Issuer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4200 MARATHON BLVD SUITE 200 AUSTIN TX 78756
Business Address
Pitukcheewanont Pisit Duke (Reporting) CIK: 0002006724 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35342 | Film No.: 24527633